XML 37 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Millions, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash Flows from Operating Activities    
Net income (loss) $ (2,626) $ 484
Adjustments to reconcile net income (loss) to net cash provided by operating activities    
Depreciation, depletion, and amortization 1,124 1,022
Deferred income taxes 46 162
Dry hole expense and impairments of unproved properties 198 177
Impairments 3 29
(Gains) losses on divestitures, net (1,459) (144)
Total (gains) losses on derivatives, net 461 199
Net cash from settlement of derivative instruments (98) 47
Other 54 44
Changes in assets and liabilities    
Algeria exceptional profits tax settlement 0 450
Tronox-related contingent loss 4,300 0
(Increase) decrease in accounts receivable (266) 40
Increase (decrease) in accounts payable and accrued expenses (63) (125)
Other items—net 55 118
Net cash provided by (used in) operating activities 1,729 2,503
Cash Flows from Investing Activities    
Additions to properties and equipment and dry hole costs (2,501) (1,710)
Acquisition of businesses (4) (135)
Divestitures of properties and equipment and other assets 3,257 361
Other—net (170) (133)
Net cash provided by (used in) investing activities 582 (1,617)
Cash Flows from Financing Activities    
Borrowings, net of issuance costs 918 385
Repayments of debt (930) 0
Increase (decrease) in outstanding checks 97 86
Dividends paid (92) (46)
Repurchase of common stock (35) (27)
Issuance of common stock, including tax benefit on share-based compensation awards 13 18
Sale of subsidiary units 18  
Sale of subsidiary units   (1)
Distributions to noncontrolling interest owners (51) (33)
Contributions from noncontrolling interest owners 0 1
Net cash provided by (used in) financing activities (62) 383
Effect of Exchange Rate Changes on Cash (23) (5)
Net Increase (Decrease) in Cash and Cash Equivalents 2,226 1,264
Cash and Cash Equivalents at Beginning of Period 3,698 2,471
Cash and Cash Equivalents at End of Period $ 5,924 $ 3,735